Last Updated: November 4, 2026

Patent: 11,167,030

✉ Email this page to a colleague

Summary for Patent: 11,167,030

Title:	Protein formulations and methods of making same
Abstract:	The invention provides an aqueous formulation comprising water and a protein, and methods of making the same. The aqueous formulation of the invention may be a high protein formulation and/or may have low levels of conductivity resulting from the low levels of ionic excipients. Also included in the invention are formulations comprising water and proteins having low osmolality.
Inventor(s):	Wolfgang Fraunhofer, Annika Bartl, Hans-Juergen Krause, Markus Tschoepe, Katharina Kaleta
Assignee:	AbbVie Biotechnology Ltd
Application Number:	US17/137,201
Patent Claims:	see list of patent claims

Details for Patent 11,167,030

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	December 31, 2002	11,167,030	2040-12-29
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	February 21, 2008	11,167,030	2040-12-29
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	April 24, 2013	11,167,030	2040-12-29
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	September 23, 2014	11,167,030	2040-12-29
Abbvie Inc.	HUMIRA	adalimumab	Injection	125057	November 23, 2015	11,167,030	2040-12-29
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 11,167,030

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
Australia	2008334099	⤷ Start Trial
Australia	2013204044	⤷ Start Trial
Australia	2013204165	⤷ Start Trial
Australia	2017203012	⤷ Start Trial
Brazil	PI0819714	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.